222 related articles for article (PubMed ID: 11865007)
1. Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squamous cell carcinoma.
Ikeguchi M; Sakatani T; Ueta T; Fukuda K; Oka S; Hisamitsu K; Yamaguchi K; Tsujitani S; Kaibara N
J Clin Pathol; 2002 Feb; 55(2):121-6. PubMed ID: 11865007
[TBL] [Abstract][Full Text] [Related]
2. bcl-2 and p53 immunophenotypes in pre-invasive, early and advanced oesophageal squamous cancer.
Parenti AR; Rugge M; Shiao YH; Ruol A; Ancona E; Bozzola L; Ninfo V
Histopathology; 1997 Nov; 31(5):430-5. PubMed ID: 9416483
[TBL] [Abstract][Full Text] [Related]
3. p53 protein accumulation in oesophageal squamous cell carcinomas and precancerous lesions.
Volant A; Nousbaum JB; Giroux MA; Roué-Quintin I; Metges JP; Férec C; Gouérou H; Robaszkiewicz M
J Clin Pathol; 1995 Jun; 48(6):531-4. PubMed ID: 7665695
[TBL] [Abstract][Full Text] [Related]
4. Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity.
Shimada Y; Watanabe G; Yamasaki S; Maeda M; Kawabe A; Kaganoi JI; Itami A; Fukumoto M; Kanda Y; Imamura M
Eur J Cancer; 2000 May; 36(8):987-93. PubMed ID: 10885602
[TBL] [Abstract][Full Text] [Related]
5. Correlation of tumor markers p53, bcl-2 and cathepsin-D with clinicopathologic features and disease-free survival in laryngeal squamous cell carcinoma.
Lazaris AC; Lendari I; Kavantzas N; Kandiloros D; Adamopoulos G; Davaris P
Pathol Int; 2000 Sep; 50(9):717-24. PubMed ID: 11012985
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma.
Ikeguchi M; Saito H; Katano K; Tsujitani S; Maeta M; Kaibara N
J Am Coll Surg; 1997 Oct; 185(4):398-403. PubMed ID: 9328389
[TBL] [Abstract][Full Text] [Related]
7. Expression of cathepsin D in transitional cell bladder tumours.
Lipponen PK
J Pathol; 1996 Jan; 178(1):59-64. PubMed ID: 8778318
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma.
Gotoda T; Matsumura Y; Kondo H; Ono H; Kanamoto A; Kato H; Watanabe H; Tachimori Y; Nakanishi Y; Kakizoe T
Gut; 2000 Jan; 46(1):14-9. PubMed ID: 10601048
[TBL] [Abstract][Full Text] [Related]
9. p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival.
Casson AG; Tammemagi M; Eskandarian S; Redston M; McLaughlin J; Ozcelik H
Mol Pathol; 1998 Apr; 51(2):71-9. PubMed ID: 9713589
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 protein in oesophageal carcinoma: clinicopathological correlation and prognostic significance.
Vijeyasingam R; Darnton SJ; Jenner K; Allen CA; Billingham C; Matthews HR
Br J Surg; 1994 Nov; 81(11):1623-6. PubMed ID: 7827889
[TBL] [Abstract][Full Text] [Related]
11. Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness?
Lam KY; Law S; Ma LT; Ong SK; Wong J
Eur J Cancer; 1997 Jul; 33(8):1221-5. PubMed ID: 9301446
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma.
Grabowski P; Kühnel T; Mühr-Wilkenshoff F; Heine B; Stein H; Höpfner M; Germer CT; Scherübl H
Br J Cancer; 2003 Jan; 88(1):115-9. PubMed ID: 12556969
[TBL] [Abstract][Full Text] [Related]
13. Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator.
Lam KY; Law S; Luk JM; Wong J
J Pathol; 2001 Nov; 195(4):435-42. PubMed ID: 11745675
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma.
Nakajima M; Fukuchi M; Miyazaki T; Masuda N; Kato H; Kuwano H
Br J Cancer; 2003 Jun; 88(11):1734-9. PubMed ID: 12771989
[TBL] [Abstract][Full Text] [Related]
15. CD117 expression in operable oesophageal squamous cell carcinomas predicts worse clinical outcome.
Fan H; Yuan Y; Wang J; Zhou F; Zhang M; Giercksky KE; Nesland JM; Suo Z
Histopathology; 2013 Jun; 62(7):1028-37. PubMed ID: 23570416
[TBL] [Abstract][Full Text] [Related]
16. TGFBR3 is an independent unfavourable prognostic marker in oesophageal squamous cell cancer and is positively correlated with Ki-67.
Zhang X; Chen Y; Li Z; Han X; Liang Y
Int J Exp Pathol; 2020 Dec; 101(6):223-229. PubMed ID: 33146446
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 in oesophageal squamous epithelium from surgical specimens resected for squamous cell carcinoma of the oesophagus, with special reference to uninvolved mucosa.
Mandard AM; Marnay J; Lebeau C; Benard S; Mandard JC
J Pathol; 1997 Feb; 181(2):153-7. PubMed ID: 9120718
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of p53, nm23, and bcl-2 in T3-4N1M0 oesophageal carcinoma: an immunohistochemical approach.
Patel DD; Bhatavdekar JM; Chikhlikar PR; Patel YV; Shah NG; Ghosh N; Suthar TP; Balar DB
J Surg Oncol; 1997 Jun; 65(2):111-6. PubMed ID: 9209522
[TBL] [Abstract][Full Text] [Related]
19. Endometrial carcinoma: immunohistochemically detected proliferation index is a prognosticator of long-term outcome.
Gassel AM; Backe J; Krebs S; Schön S; Caffier H; Müller-Hermelink HK
J Clin Pathol; 1998 Jan; 51(1):25-9. PubMed ID: 9577367
[TBL] [Abstract][Full Text] [Related]
20. p53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium.
Chaves P; Pereira AD; Pinto A; Oliveira AG; Queimado L; Gloria L; Cardoso P; Mira FC; Soares J
J Surg Oncol; 1997 May; 65(1):3-9. PubMed ID: 9179260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
